Biomea Fusion, Inc. (BMEA) vs Cumberland Pharmaceuticals Inc. (CPIX)
A side-by-side comparison of Biomea Fusion, Inc. and Cumberland Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMEA
Biomea Fusion, Inc.
$1.26HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
CPIX
Cumberland Pharmaceuticals Inc.
$7.07HealthcareDelayed quote: Oct 6, 2026, 3:33 PM EDT
Total return — BMEA vs CPIX
growth of $100 · dividends reinvested · last 5yBMEA -92.4% (-40.2%/yr)CPIX +170.4% (+22.0%/yr)CPIX compounded faster over this window
Log scale — wide-divergence pair
BMEA CPIX
BMEA vs CPIX: by the numbers
- •CPIX is the larger company ($106M vs $91M market cap).
- •Both run net losses; BMEA's is the smaller (0.00% vs -33.92% net margin).
- •CPIX pays a dividend (21.16% yield), while BMEA has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BMEA | CPIX |
|---|---|---|
| P/S ratio | N/A | 3.39 |
| P/B ratio | 7.48 | 6.07 |
Profitability
| Metric | BMEA | CPIX |
|---|---|---|
| Gross margin | 0.00% | 83.37% |
| Operating margin | 0.00% | -6.27% |
| Net margin | 0.00% | -33.92% |
| ROE | -268.09% | -60.82% |
| ROIC | -220.02% | -34.77% |
Dividends
| Metric | BMEA | CPIX |
|---|---|---|
| Dividend yield | N/A | 21.16% |
Growth (annualized)
| Metric | BMEA | CPIX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 3.53% |
| Total return CAGR (5Y) | -36.56% | 25.62% |
Frequently asked
- Does BMEA or CPIX pay a bigger dividend?
- CPIX pays a dividend (21.16% yield), while BMEA has no payments in the available dividend history.
- How have BMEA and CPIX total returns compared?
- Over the past 5 years, BMEA delivered -36.56% and CPIX delivered 25.62% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cumberland Pharmaceuticals dividend yieldBiomea Fusion ROECumberland Pharmaceuticals ROEBiomea Fusion operating marginCumberland Pharmaceuticals operating marginBiomea Fusion revenue growthCumberland Pharmaceuticals revenue growthBiomea Fusion free cash flowCumberland Pharmaceuticals free cash flow
Biomea Fusion & Cumberland Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.